Our research presents a new perspective, suggesting that ERα contributes to pro-tumor effects by shaping the BLCA tumor environment, which may help explain why female BLCA patients often have a poor prognosis and could open up new avenues for potential treatments. This evidence concerns the gene ESR1 and bladder transitional cell carcinoma.